Persistierendes Foramen ovale und ischämischer Schlaganfall: Aktuelle Aspekte

Abstract

The value of interventional closure of patent foramen ovale (PFO) after cryptogenic stroke has been controversial. Recently, two randomized controlled trials showed a benefit of interventional closure of PFO compared to antiplatelet therapy only. We give a survey of the current literature and express questions that still remain unacknowledged.

Das persistierende Foramen ovale kann mit einem ischämischen Schlaganfall zusammenhängen. Sollte es also interventionell verschlossen werden? Leitlinien raten noch zur Zurückhaltung, aber aktuelle Studien zeigen, dass der Eingriff bei einigen Patienten durchaus sinnvoll sein kann. Ein Standpunkt-Artikel aus der Sicht eines Neurologen, in dem auch die noch offenen Fragen betont werden.

Schlüsselwörter

Persistierendes Foramen ovale (PFO) - PFO-Verschluss - ischämischer Schlaganfall - kryptogener Schlaganfall

Key words

patent foramen ovale (PFO) - closure of PFO - ischemic stroke - cryptogenic stroke

• Literatur

• 1 Mas JL, Derumeaux G, Guillon B. et al. Patent Foramen Ovale Closure or Anticoagulation vs. Platelets after Stroke. N Engl J Med 2017; 377: 1011-1021
• 2 Søndergaard L, Kasner SE, Rhodes JF. et al. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med 2017; 377: 1033-1042
• 3 Saver JL, Carroll JD, Thaler DE. et al. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med 2017; 377: 1022-1032
• 4 Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20
• 5 Lechat P, Mas JL, Lascault G. et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-1152
• 6 Farb A, Ibrahim NG, Zuckerman BD. Patent Foramen Ovale after Cryptogenic Stroke – Assessing the Evidence for Closure. N Engl J Med 2017; 377: 1006-1009
• 7 Sun YP, Homma S. Patent Foramen Ovale and Stroke. Circ J 2016; 80: 1665-1673
• 8 Kent DM, Ruthazer R, Weimar C. et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 2013; 81: 619-625
• 9 Furlan AJ, Reisman M, Massaro J. et al. Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale. N Engl J Med 2012; 366: 991-999
• 10 Meier B, Kalesan B, Mattle HP. et al. Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism. N Engl J Med 2013; 368: 1083-1091
• 11 Carroll JD, Saver JL, Thaler DE. et al. Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke. N Engl J Med 2013; 368: 1092-1100
• 12 Messé SR, Gronseth G, Kent DM. et al. Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter). Neurology 2016; 87: 815-821
• 13 Kernan WN, Ovbiagele B, Black HR. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160-2236
• 14 Deutsche Gesellschaft für Neurologie, Deutsche Schlaganfallgesellschaft. Primär- und Sekundärprävention der zerebralen Ischämie: Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurologie (DGN) und der Deutschen Schlaganfallgesellschaft (DSG). 2008
• 15 Homma S, Sacco RL, Di Tullio MR. et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-2631
• 16 Shariat A, Yaghoubi E, Farazdaghi M. et al. A comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial. J Res Med Sci 2013; 18: 94-98
• 17 Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS). Im Internet: clinicaltrials.gov https://clinicaltrials.gov/ct2/show/NCT02239120?cond=Respect+Esus&rank=1 ; Stand: 18.01.2018
• 18 Apixaban for Treatment of Embolic Stroke of Undetermined Source. Im Internet: clinicaltrials.gov https://clinicaltrials.gov/ct2/show/NCT02427126?cond=Apixaban+for+Treatment+of+Embolic+Stroke+of+Undetermined&rank=1 ; Stand: 18.01.2018
• 19 Staubach S, Steinberg DH, Zimmermann W. et al. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv 2009; 74: 889-895